Pharma: Page 42
-
PharmaVoice Team/PharmaVoice
Red Jacket Al Altomari
A Value-Based Leader Al Altomari Title: Chairman and CEO Company: Agile Therapeutics Awards/Honors: Hall of Fame Father Judge High School, 2017; Hall of Fame, Drexel 100, 2017; CEO of the Year, Finance Magazine, 2016; Father of the Year, American Diabetes Association, 2015; CEO of the Year, New J...
By Al Altomari • Aug. 1, 2020 -
PharmaVoice Team/PharmaVoice
Red Jacket Sharon Callahan
A Call to Action Raising the bar… by calling people to take action Sharon Callahan Title: CEO Company: CDM Personal awards: Healthcare Businesswomen’s Association (HBA) STAR, 2006; PharmaVOICE 100, 2020 (Red Jacket), 2019, 2017; MedAdNews, Industry Person of the Year, 2019; HBA Woman of the Year,...
By Sharon Callahan • Aug. 1, 2020 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Red Jacket Dr. Nancy A. Dreyer
Shaping the Future of Real-World Evidence Raising the bar… with the help of others Nancy Dreyer, Ph.D. Title: Chief Scientific Officer and Senior VP Company: IQVIA Industry Awards: 2019 Author of the Year, DIA Inspire Award Associations: Drug Information Association; International Society of Pha...
By Dr. Nancy A. Dreyer • Aug. 1, 2020 -
PharmaVoice Team/PharmaVoice
Red Jacket Barry Greene
Every Single Patient Matters Raising the bar… by bringing interconnectivity into everything we do Barry Greene Title: President Company: Alnylam Pharmaceuticals Awards/Honors: Albert Einstein Award; 2008 Pharmaceutical Executive 45 Under Forty Five; 2008 The 11th Annual Myer Saxe Award from the ...
By Barry Greene • Aug. 1, 2020 -
PharmaVoice Team/PharmaVoice
Red Jacket Julie Ross
Steering Toward the Quantum Leap Raising the bar… by constantly challenging the status quo Julie Ross Title: President Company: Advanced Clinical Industry Awards: 2019 Healthcare Businesswomen’s Association’s Chair Award; 2016, 2014 PharmaVOICE 100 Company Awards: 2019 Outstanding Leader; 2018 Ou...
By Julie Ross • Aug. 1, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Raising the bar … Last month, I noted that the life-sciences industry has the opportunity to be extraordinary amidst the continuing global pandemic. As we continue to mourn the mounting losses attributed to this global crisis, I am heartened to see how people from companies of all sizes and types...
By Taren Grom • June 1, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Road Ahead As we head into 2020, closing out a decade punctuated by an ever-changing healthcare dynamic shaped by scientific discoveries, technological breakthroughs, innovation at every level, as well as global geopolitical forces, there is no doubt that the status quo is no longer a busines...
By Taren Grom • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Small Pharma Driving Big Pharma Innovation
The Path to R&D Innovation Lies in the Power of Small Pharma Visionary thought leaders such as Bernard Munos of InnoThink and the Milken Institute and Paul Stoffels, M.D., vice chairman of the executive committee and chief scientific officer, Johnson & Johnson, have been advocating for ye...
By Robin Robinson • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
SHOWCASE: High-Science Brands: Making Connections for High Science Brands
The growth of high-science brands has changed the life sciences landscape, and with it the strategies companies need to develop to market their products must also undergo a significant shift. Cancer immunotherapies as well as other high-science brands will account for $34 billion in sales by 2024...
By PharmaVoice Team • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
High-Science Storytelling: Cracking the Code on Meaningful Messaging
In full transparency, I am a high-science geek. I am jazzed by data, by new technologies and pathways, but most importantly, I am particularly motivated when I have the ability to work on clinically meaningful advancements that truly make a difference in patients’ lives. I am the one in the crowd...
By Amy Graham • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
After Approval, Can Gene Therapies Achieve Marketing Success?
Having a well-designed plan that addresses the needs of all stakeholders — patients and their families, medical institutions, payers and manufacturers — will help drive successful outcomes. The advent of gene therapy — personalized medicine reflecting the potential to minimize or cure disease — i...
By Denise Myshko • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Real-Time Hope for Rare Diseases
With advances in genomics sequencing combined with AI and other tools to speed up data analysis, the potential for quickly diagnosing and ultimately developing therapies that can treat patients with rare diseases in real time grows. The rare diseases space has come on leaps and bounds over the pa...
By Kim Ribbink • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
The Changing Role of the Traditional Pharma Brand
Experts say the industry needs to reinvent its role to create value in diagnostics, prevention, and digital health solutions beyond its traditional brands. According to a Strategy& report out earlier this year, healthcare will be centered on patients who are empowered to prevent diseases rath...
By Robin Robinson • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Imagine if… When we introduced the PharmaVOICE 100 most inspiring people in the life-sciences industry 15 years ago it began a movement. We sought to capture that intangible measure of a person’s influence: inspiration. And we thought who better to identify these individuals than you, our readers...
By Taren Grom • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 Who's on the List - By Category
Who’s on the List — 2019 Indexed by Category Commanders & Chiefs Paul Balagot precisioneffect Percival Barretto-Ko Astellas US Udit Batra MilliporeSigma Dan Bradbury Equillium Dr. Pablo Cagnoni Rubius Therapeutics Sharon Callahan TBWA\WorldHealth Dr. Donald Deieso WIRB-Copernicus Group Drew D...
By PharmaVoice Team • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
Researchers & Scientists
These visionary thinkers are driving innovation around scientific breakthroughs and new technologies. Fierce Advocate. Collaborative. Uniting for Cures Shao-Lee Lin, M.D., Ph.D. Title: Executive VP, Head of Research and Development, and Chief Scientific Officer Company: Horizon Charged with build...
By PharmaVoice Team • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
2019 Red Jacket Honorees
Leaders for today and tomorrow PharmaVOICE introduced the Red Jacket Award, now in its fifth year, to celebrate the 10th anniversary of the PharmaVOICE 100. One of the criteria for being named a Red Jacket — our version of a Hall of Fame — is having been recognized previously as a PharmaVOICE 100...
By PharmaVoice Team • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
Red Jacket Chris Perkin
Chris Perkin Title: CEO Company: Altasciences Industry Awards: PharmaVOICE 100, 2015, 2016, 2017, 2018; Gamechangers of the Year, 2018 Company Awards: Clinical and Research Excellence Awards (CARE), Winner, Most Successful Early Phase Research, 2019; Top 10 CRO, Pharma Tech Outlook magazine, 2019...
By Chris Perkin • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
Anything But Generic Leadership Marc Kikuchi, the newly appointed CEO of Dr. Reddy’s North America — and a 2015 PharmaVOICE 100 — discusses trends in the generics industry and how he is positioning the company for success. PV: What are some of the biggest issues impacting the U.S. generics indust...
By Marc Kikuchi • June 1, 2019 -
PharmaVoice Team/PharmaVoice
The Realities of VR and AR in the Industry
Pharma brings complicated material to life with augmented and virtual reality. Imagine you are standing in your exhibit booth on a very crowded scientific and educational meeting floor, armed with fascinating, yet difficult-to-understand medical content that needs to make its way to the many pass...
By Robin Robinson • June 1, 2019 -
PharmaVoice Team/PharmaVoice
The Agile R&D Organization
A project management philosophy popular among technology companies has learnings for pharma R&D. Agile project management, first introduced in 2001, started out as a method used in software development that challenged the traditional, linear development model. The same benefits realized by th...
By Denise Myshko • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Upfront
Amgen Hosts Amgen Biotech Experience Meeting The Amgen Foundation recently hosted lab technicians who participated in the Amgen Biotech Experience (ABE). The meeting, held at Amgen’s headquarters in Thousand Oaks, Calif., allowed the lab technicians, who administer ABE to science teachers, to net...
By PharmaVoice Team • May 1, 2019 -
PharmaVoice Team/PharmaVoice
The Biosimilars Market
While the bulk of activity in the biosimilar space has taken place outside of the United States, the approval and uptake of biosimilars in the United States is expected to pick up over the next five years. The biosimilar industry has developed rapidly, and regulations have advanced significantly ...
By Denise Myshko • May 1, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The year ahead… As we come to the end of 2018, it’s important to pause and reflect on not just where we’ve been, but where we are going as an industry. In 2018, we saw continuing uncertainty in terms of the Affordable Care Act. We welcomed Alex Azar as the new Secretary of Health and Human Servic...
By Taren Grom • Nov. 15, 2018 -
PharmaVoice Team/PharmaVoice
Nontraditional Pharma Companies
As for-profit life-sciences companies abandon medicines that do not add to the corporate bottom line, nonprofit and nontraditional organizations are pursuing these promising treatments to provide patient populations with important medicines, vaccines, and generics. One such nonprofit company that...
By Robin Robinson • Oct. 1, 2018
Previous
